nach oben

Erschienen in:

01.07.2022 | Clinical study

Two-dose Ebola vaccine regimen generally well tolerated

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

The UMURINZI ((Unprecedented Movement to drive a Unified Rwandan Initiative for National ZEBOVAC Immunization) Ebola vaccination campaign in Rwanda, a two-dose Ebola vaccine regimen consisting of Ad26.ZEBOV followed by MVA-BN-Filo, is generally safe and well tolerated, with only rare reports of febrile convulsions in young children, say authors of a study published in the Journal of Infectious Diseases. …

Nyombayire J, et al. Monitoring of adverse events in recipients of the 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign Journal of Infectious Diseases : 11 Jul 2022. Available from: URL: https://doi.org/10.1093/infdis/jiac283

Titel: Two-dose Ebola vaccine regimen generally well tolerated
Publikationsdatum: 01.07.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-19040-8

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Two-dose Ebola vaccine regimen generally well tolerated

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Immune-globulin

Clozapine

Multiple drugs

Immune globulin/antibacterials/corticosteroids

Immune-globulin/prednisolone

Antineoplastics/folinic-acid